Attached files
| file | filename |
|---|---|
| EX-99.1 - PHARMACYCLICS INC | ex991to8k07380_12042009.htm |
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December
3, 2009
|
PHARMACYCLICS,
INC.
|
||
|
(Exact
name of registrant as specified in its charter)
|
||
|
Delaware
|
000-26658
|
94-3148201
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
995
E. Arques Avenue
Sunnyvale,
California
|
94085-4521
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Registrant’s
telephone number, including area code: (408)
774-0330
|
|
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
8.01
|
Other
Events.
|
On
December 3, 2009, Pharmacyclics, Inc. a Delaware corporation (the "Registrant"),
announced that it will host a webcast and conference call on, Tuesday, December
8, 2009 at 11:00am Eastern Time (10:00am Central Time and 8:00am Pacific Time)
to discuss clinical data regarding its HDAC Program (PCI-24781) and its BTK
Program (PCI-32765) that will be presented at the American Society of Hematology
(ASH) meeting.
The
foregoing description is qualified in its entirety by reference to the
Registrant's Press Release dated December 3, 2009, a copy of which is attached
hereto as Exhibit 99.1 and incorporated herein by reference.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
(d) Exhibits.
|
Exhibit No.
|
Description
|
||
|
99.1
|
Press
Release of Pharmacyclics, Inc. dated December 3,
2009.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: December
4, 2009
|
PHARMACYCLICS,
INC.
|
|||
|
By:
|
/s/
RAINER ERDTMANN
|
||
|
Name:
|
Rainer
Erdtmann
|
||
|
Title:
|
Vice
President of Finance
|
||
INDEX
TO EXHIBITS
|
Exhibit No.
|
Description
|
||
|
99.1
|
Press
Release of Pharmacyclics, Inc. dated December 3,
2009.
|